Clinical trials
Completed Anemia, Refractory, with Excess of Blasts trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
160 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 16 |
| 2001 | 10 |
| 2002 | 12 |
| 2003 | 7 |
| 2004 | 13 |
| 2005 | 11 |
| 2006 | 6 |
| 2007 | 5 |
| 2008 | 3 |
| 2009 | 5 |
| 2010 | 9 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 8 |
| 2014 | 2 |
| 2015 | 3 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 160 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 20 |
| Fred Hutchinson Cancer Center | 16 |
| Memorial Sloan Kettering Cancer Center | 10 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 10 |
| Case Comprehensive Cancer Center | 8 |
| M.D. Anderson Cancer Center | 5 |
| National Heart, Lung, and Blood Institute (NHLBI) | 5 |
| Roswell Park Cancer Institute | 5 |
| University of California, San Francisco | 5 |
| University of Washington | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia, Refractory, with Excess of Blasts | 160 |
| Myelodysplastic Syndromes | 97 |
| Leukemia | 95 |
| Leukemia, Myeloid, Acute | 90 |
| Leukemia, Myelomonocytic, Chronic | 89 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 71 |
| Myeloproliferative Disorders | 56 |
| Anemia, Refractory | 50 |
| Congenital Abnormalities | 49 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 43 |
Trials
Showing 1 to 25 of 160. Each trial links to its page on Pharma Observatory.
60 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.